Docoh
Loading...

NURO Neurometrix

News

From Benzinga Pro
NeuroMetrix Q4 Sales $1.82M Up From $1.81M YoY
27 Jan 22
Earnings, News
NeuroMetrix (NASDAQ:NURO) reported $1.82 million in sales this quarter. This is a 0.55 percent increase over sales of $1.81 million the same period last year.
Earnings Scheduled For January 27, 2022
27 Jan 22
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • SAP (NYSE:SAP) is estimated to report quarterly earnings at $1.87 per share on revenue of $9.10 billion.
Neurometrix Shares Spike To Session High, Immediately See Profit Taking, Following Circulation Of US National Institutes Of Health ClinicalTrials.gov Listing For Co.'s 'Electrical Stimulation for Post Acute COVID-19 Syndrome'
21 Jan 22
Biotech, News, FDA, Movers, Trading Ideas, General
https://clinicaltrials.gov/ct2/show/NCT05200858
12 Health Care Stocks Moving In Thursday's Pre-Market Session
20 Jan 22
Pre-Market Outlook, Markets, Movers
52 Biggest Movers From Yesterday
20 Jan 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares surged 65.7% to close at $25.92 on Wednesday after the company announced it will be acquired by UCB for approximately $1.9 billion.
12 Health Care Stocks Moving In Wednesday's Intraday Session
19 Jan 22
Intraday Update, Markets, Movers
35 Stocks Moving In Wednesday's Mid-Day Session
19 Jan 22
News, Intraday Update, Markets, Movers, Trading Ideas
Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares jumped 67.1% to $26.15 after the company announced it will be acquired by UCB for approximately $1.9 billion.
65 Biggest Movers From Yesterday
19 Jan 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Brickell Biotech, Inc. (NASDAQ: BBI) shares jumped 58.6% to settle at $0.33 on Tuesday after HC Wainwright & Co initiated coverage on the stock with a Buy rating and $2 price target.
Mid-Afternoon Market Update: Dow Dips 500 Points; NeuroMetrix Shares Spike Higher
18 Jan 22
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Toward the end of trading Tuesday, the Dow traded down 1.4% to 35,410 while the NASDAQ fell 2.12% to 14,577.79. The S&P also fell, dropping, 1.60% to 4,588.10.
12 Health Care Stocks Moving In Tuesday's Intraday Session
18 Jan 22
Intraday Update, Markets, Movers
Mid-Day Market Update: Nasdaq Tumbles 250 Points; Activision Blizzard Shares Jump
18 Jan 22
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Midway through trading Tuesday, the Dow traded down 1.58% to 35,343.17 while the NASDAQ fell 1.70% to 14,640.00. The S&P also fell, dropping, 1.57% to 4,589.66.
34 Stocks Moving In Tuesday's Mid-Day Session
18 Jan 22
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares gained 37.2% to $6.75 after the company eeceived FDA Breakthrough Device Designation for the treatment of chronic chemo induced peripheral neuropathy with its wearable neurostimulation technology.
NeuroMetrix Shares Rally On FDA Breakthrough Tag For Neurostimulation Device
18 Jan 22
Long Ideas, News, Health Care, FDA, Movers, Trading Ideas, General
The
Mid-Morning Market Update: Markets Open Lower; Goldman Sachs Earnings Miss Views
18 Jan 22
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Following the market opening Tuesday, the Dow traded down 1.52% to 35,366.17 while the NASDAQ fell 1.15% to 14,722.00. The S&P also fell, dropping, 1.32% to 4,601.52.
NeuroMetrix Reports Received FDA Breakthrough Device Designation For Treatment Of Chronic Chemo Induced Peripheral Neuropathy With Its Wearable Neurostimulation Technology
18 Jan 22
Biotech, News, FDA, General
NeuroMetrix, Inc. (NASDAQ:NURO) today announced that its Quell® technology has received Breakthrough Designation from the U.S. Food and Drug Administration (FDA) for reducing moderate to severe symptoms of
Watching Neurometrix, Tellerian, Nxt-ID, Bark Shares Following Recent Pennystocks.com Article 'Best Penny Stocks To Buy Now? 4 On Webull With Bullish User Ratings'
12 Jan 22
Media, Trading Ideas
https://pennystocks.com/featured/2022/01/12/best-penny-stocks-to-buy-now-4-on-webull-bullish-user-ratings/
NeuroMetrix Granted U.S. Patent Titled 'Detecting cutaneous electrode peeling using electrode-skin impedance'
7 Dec 21
News, Legal
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6546&f=G&l=50&d=PTXT&p=131&S1=20211207&OS=20211207&RS=20211207
12 Health Care Stocks Moving In Monday's After-Market Session
1 Nov 21
Movers
Gainers Biophytis (NASDAQ:BPTS) shares moved upwards by 37.54% to $8.5 during Monday's after-market session. The market value of their outstanding shares is at $106.8 million.